Cargando…

Comparison of Prices for Commonly Administered Drugs in Employer-Sponsored Insurance Relative to Medicare

This cross-sectional study compares unit prices and price growth in employer-sponsored insurance and Medicare over 2016 through 2020 for physician-administered drugs with the highest use and those with the highest spending.

Detalles Bibliográficos
Autores principales:	Chang, Jessica Y., Sen, Aditi P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918879/ https://www.ncbi.nlm.nih.gov/pubmed/36763370 http://dx.doi.org/10.1001/jamahealthforum.2022.5422

Ejemplares similares

Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019
por: League, Riley J., et al.
Publicado: (2022)

Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
por: Ray, Markqayne, et al.
Publicado: (2023)

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population
por: Li, Mengyao, et al.
Publicado: (2023)

Trends in Enrollment in Employer-Sponsored Health Insurance in the US Before and During the COVID-19 Pandemic, January 2019 to June 2021
por: Parikh, Ravi B., et al.
Publicado: (2022)

Preventing Financial Strain for Low- and Moderate-Income Adults: a Comparison of Medicaid, Marketplace, and Employer-Sponsored Insurance
por: Saluja, Sonali, et al.
Publicado: (2021)

Sources of Geographic Variation in Health Care Spending Among Individuals With Employer Sponsored Insurance
por: Johnson, William C., et al.
Publicado: (2020)

Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
por: Cantor, Jonathan, et al.
Publicado: (2021)

ENTERING MEDICARE ADVANTAGE FROM EMPLOYER-SPONSORED PLANS: CHANGE IN OUT-OF-POCKET COSTS AND UTILIZATION AT AGE 65
por: Hames, Alexandra Glynn, et al.
Publicado: (2022)

Employer and Plan Sponsor Views on Pharmacy Reimbursement
por: Stull, Michael, et al.
Publicado: (2020)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Price Comparison of Human and Veterinary Formulations of Common Medications
por: Haque, Waqas, et al.
Publicado: (2022)

Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
por: Berenson, Robert A., et al.
Publicado: (2019)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
por: Kurtyka, Karen, et al.
Publicado: (2016)

The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health Insurance
por: Herman, William H., et al.
Publicado: (2021)

Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2008
por: DePue, Ronnie, et al.
Publicado: (2008)

Vaping in the Workplace: Implications for Employer-Sponsored Tobacco Cessation Programs
por: Graham, Amanda L., et al.
Publicado: (2020)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
por: Lu, Jinmiao, et al.
Publicado: (2023)

The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare
por: Lin, Eugene
Publicado: (2021)

Health-related employer support, recurring pain, and direct insurance costs for a self-insured employer
por: Williams, Jessica AR
Publicado: (2015)

How Has Access to Care for Medi-Cal Enrollees Fared Relative to Employer-Sponsored Insurance 4 Years After the Affordable Care Act Expansion?
por: Babey, Susan H., et al.
Publicado: (2022)

The reaction of sponsor stock prices to clinical trial outcomes: An event study analysis
por: Singh, Manish, et al.
Publicado: (2022)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Utilization and Cost of an Employer-Sponsored Comprehensive Primary Care Delivery Model
por: Basu, Sanjay, et al.
Publicado: (2020)

Relationship Between Adherence to Antihypertensive Medication Regimen and Out-of-Pocket Costs Among People Aged 35 to 64 With Employer-Sponsored Health Insurance
por: Baker-Goering, Madeleine M., et al.
Publicado: (2019)

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
por: Mostaghimi, Arash, et al.
Publicado: (2023)

Pricing in General Insurance
por: Parodi, Pietro
Publicado: (2014)

Association Between Waste-Free Formularies and Prescription Drug Spending Among Self-insured Employers
por: Socal, Mariana P., et al.
Publicado: (2021)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Physician Network Breadth and Plan Quality Ratings in Medicare Advantage
por: Sen, Aditi P., et al.
Publicado: (2021)

Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism
por: Zin, Che Suraya, et al.
Publicado: (2020)

How Do the Hospital Prices Paid by Medicare Advantage Plans and Commercial Plans Compare With Medicare Fee-for-Service Prices?
por: Maeda, Jared Lane K., et al.
Publicado: (2018)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition
por: Dickson, Sean R., et al.
Publicado: (2021)

Trends in Use of Robotic Surgery for Privately Insured Patients and Medicare Fee-for-Service Beneficiaries
por: Bonner, Sidra N., et al.
Publicado: (2023)

Predictors of Weight Loss Maintenance following an Insurance-Sponsored Weight Management Program
por: Abildso, Christiaan G., et al.
Publicado: (2014)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Changes in Drug List Prices and Amounts Paid by Patients and Insurers
por: Yang, Eric J., et al.
Publicado: (2020)

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance
por: Johnston, Kenton J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gftj34amgf8o4mdbk11s688fbg